Up-regulation of NOX2 has been reported in the pathogenesis of Parkinson's disease in human patients and animal models (Glass et al., 2010), and NOX2 enzyme activation was also found in patients with chronic inflammatory demyelinating polyneuropathy (Marrali et al., 2016). This evidence concerns the gene CYBB and chronic inflammatory demyelinating polyradiculoneuropathy.